Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology... see more

TSX:CPH - Post Discussion

Cipher Pharmaceuticals Inc > Debt-Free CPH: At 1.5 times its 2020 EBITDA And The Buyback
View:
Post by stockfy on Feb 20, 2021 5:18am

Debt-Free CPH: At 1.5 times its 2020 EBITDA And The Buyback

pabaloo alias, you sold CPH but CPH is debt-free with a significant amount of cash, so its current Enterprise Value is just about 1.5 times its 2020 EBITDA. Dirt-cheap.
 
Thanks to its pristine balance sheet, CPH is seeking new growth opportunities, see excerpts from the latest Conference Call:
 
"The COVID-19 pandemic continued to impact the economy during the third quarter of 2020. Cipher is navigating through this environment while executing on business improvements and cost reductions. Cipher demonstrated strong profitability during the third quarter and sequential growth in revenue, despite market conditions that have not fully normalized. Our focus continues to be on driving profitability, strengthening the balance sheet and looking for the right opportunities for growth. "
 
"Cipher’s business and operations have demonstrated resilience as the COVID-19 pandemic continues to impact the world with the profitable business in a reduced cost structure, we feel that we are in an excellent position to start ramping up strategic promotional efforts to drive market share in our core brands and looking for the right opportunity to return Cipher to growth."


You also missed the fact that CPH bought back 205,000 shares in Q4 2020, when its average price was CAD$1 per share, facts below:

"Update on normal course issuer bid ("NCIB") program: During the quarter ended December 31, 2020 Cipher purchased for cancellation 205,500 common shares under the NCIB program."


https://cipher.investorroom.com/2021-02-10-Cipher-Pharmaceuticals-Enters-into-Co-Promotion-Agreement-with-Verity-Pharmaceuticals-Inc


Reminder. CPH bought back another 30,000 shares in Q3 2020 at C$1.14, facts below:
 
"During the period ended September 30, 2020, the Company purchased for cancellation 30,000 common shares at an average price of CAD$1.14 per common share."
 
Comment by Stocker46 on Feb 24, 2021 7:50pm
Just bought shares in CPH today. Net Earnings of approx. $4.7M for 9 months ended September 30. Shares outstanding under 27 million. Why is this company not trading much higher .. what am I missing ?
Comment by Northforce13 on Feb 24, 2021 8:22pm
What ur missing is that 10 years ago the share price was the same as it is today.  So if you bought regular stocks 10 years ago ur up 150%.  If you bought this, ur up 0%.  Cuz they sometimes make really dumb acquisitions then have to write them off, wiping out all their profits. U shud maybe research these things before you buy, instead of buying then asking others what ur missing ...more  
Comment by stockfy on Feb 25, 2021 4:54am
It seems that we have a couple of haters here who post lies. It seems they bought CPH at $15 a few years ago. Northface13 alias, get the facts straight. How you made so many inaccurate statements in such a brief comment is beyond me. How did you miss that those who bought CPH at $1 in 2011, made 1,400% in 2015 when it exceeded $15? Another lie you posted is that profitable debt-free ...more  
Comment by faraj69 on Feb 25, 2021 8:24am
Shutup Stockfy there's no demand for this stock. Doesn't matter how many shares outstanding. There's no demand left and the demand they did have, they left because of the way Craig runs this zombie of a company. Keep posting your garbage stockfy it isn't going to change the share price.
Comment by Northforce13 on Feb 25, 2021 10:20am
It's always amusing to post something negative about a stock and watch some longs come out in a panic with rose colored glasses and zero logic.  Cognitive dissonance Didn't miss that at all.  They are writing off 5.4 mil USD for something they bought in the past and which is generating zero revenue.  Great purchase.  So, yeah, like you point out, the money they spent ...more  
Comment by PitchinPennies on Feb 26, 2021 3:01pm
Fantastic exercise in hair-splitting from Mr. Paid Claque. Craig will read it and gladly slip another $12.50 in your tip jar, so the pizza's on Cipher tonight. As for those of us who did pay $15 per share in the belief that this company might be going somewhere, you are quite correct to categorize us as "haters." Speaking for myself, I do hate it when morons mess up what might have ...more  
Comment by Stocker46 on Mar 01, 2021 5:08pm
You're absolutely correct Northforce. I focused on their financials over the past 2 years. I did scan the news releases over the same period but obviously missed part of the one from January 15. From what I can tell, the Trulance fiasco began about a year before Craig Mull joined Cipher. Hopefully it's a one shot mistake. Those who have been following the company for much longer than I ...more  
Comment by pabaloo on Mar 02, 2021 1:04pm
Trulance was a huge coo for the company negotiating around Bausch to steal the Canadian rights from a now defunct Synergy Pharma. Bausch then bought out the bankrupt company without the Canadian rights. Along came the new management team at Cipher and somehow bungled up the contract and subsequent lawsuit costing them there entire investment plus cost to be determined at a later date. This alone ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities